1 – 10 of 19
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2024
- 
                        Mark
        Long-term effects of cholinesterase inhibitors and memantine on cognitive decline, cardiovascular events, and mortality in dementia with Lewy bodies : An up to 10-year follow-up study
    
    - Contribution to journal › Article
 
- 2021
- 
                        Mark
        Predictors of mortality in patients with different apolipoprotein E genotypes—a 20-year follow-up of Alzheimer’s disease.
    (2021) 15th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2021)- Contribution to conference › Abstract
 
- 2020
- 
                        Mark
        Cerebro-spinal fluid biomarker levels : phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease
    
    - Contribution to journal › Article
 
- 2018
- 
                        Mark
        Short-term response to cholinesterase inhibitors in Alzheimer’s disease delays time to nursing home placement
    
    - Contribution to journal › Article
 
- 
                        Mark
        Cerebrospinal fluid biomarker levels: Total tau and phosphorylated tau as markers for rate of progression in Alzheimer’s disease.
    (2018) Advances in Alzheimer’s and Parkinson’s Therapies (AAT-AD/PD) Focus Meeting 2018- Contribution to conference › Abstract
 
- 
                        Mark
        Economic Evaluation of Pharmacological Treatments in Dementia Disorders - A Systematic Literature Review
    (2018) In Working Papers- Working paper/Preprint › Working paper
 
- 2017
- 
                        Mark
        Early- versus late-onset Alzheimer disease : Long-term functional outcomes, nursing home placement, and risk factors for rate of progression.
    
    - Contribution to journal › Article
 
- 
                        Mark
        The outcomes of different assessment scales can predict survival in patients with Alzheimer’s disease
    (2017) 13th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2017) In Neurodegenerative Diseases 17(Suppl. 1). p.27-27- Contribution to journal › Published meeting abstract
 
- 
                        Mark
        Early- versus late-onset Alzheimer's disease in clinical practice : Cognitive and global outcomes over 3 years
    
    - Contribution to journal › Article
 
- 2016
- 
                        Mark
        Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.
    
    - Contribution to journal › Article
 
